Skip to main content
. Author manuscript; available in PMC: 2016 May 4.
Published in final edited form as: Neuropharmacology. 2015 Oct 19;101:490–505. doi: 10.1016/j.neuropharm.2015.10.020

Figure 4. Effects of DPCPX, an A1 receptor antagonist, on locomotor-related output parameters.

Figure 4

A: time-course plots showing a decrease in locomotor burst amplitude which is not statistically significant and a significant decrease in motor burst duration and cycle period (1μM, 20 minutes; n = 5). Each point represents 1 minute worth of recording. B: pooled data, averaged of 5 minutes worth of recordings in each condition, showing a significant decrease in burst duration and cycle period after the application of DPCPX (n = 5). *Significantly different from control.